$Eagle Pharmaceuticals (EGRX.US)$In the past 5 years, revenu...

逍遥投资派 commented on a stock · May 21, 2023 09:36

$Eagle Pharmaceuticals(EGRX.US)$In the past 5 years, revenue continued to shrink in the first 4 years, skyrocketed 84.6% in 2022, fluctuated for 4 years, and surged to 81 million in 2022. Net profit continued to shrink until 1 year of loss in 2021, and grew to 36 million in 2022.

2023Q1 revenue fell 43%, operating profit fell 80.3%, and net profit fell 87%. This once again confirms that the probability of a sustainable surge is very low and needs to be treated very carefully.

Currently, the price-earnings ratio is 7.8, and the cumulative profit for the past 4 quarters is in a loss state. We need to observe a few more quarters before making a judgment.

Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more

See Original

Report

3233 Views

Comment

逍遥投资派

509Followers

33Following

2870Visitors